| Michelle Beeloo, PHARMD | |
|
3851 4th St N, St Petersburg, FL 33703 | |
| (727) 822-6896 | |
| Not Available |
| Full Name | Michelle Beeloo |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3851 4th St N, St Petersburg, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063842953 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PS50994 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Beeloo, PHARMD 3851 4th St N, St Petersburg, FL 33703 Ph: (727) 822-6896 | Michelle Beeloo, PHARMD 3851 4th St N, St Petersburg, FL 33703 Ph: (727) 822-6896 |
News Archive
The Reproductive Health Drugs Advisory Committee met today to discuss the new drug application (NDA) for flibanserin 100 mg as a treatment for Hypoactive Sexual Desire Disorder (HSDD) in pre-menopausal women. The advisory committee was convened by and makes recommendations to the U.S. Food and Drug Administration (FDA). The FDA will consider the committee's advice as part of its final assessment of the NDA.
The risk of developing autism-spectrum disorders is determined by the mother's microbiome - the collection of microorganisms that naturally live inside us - during pregnancy, new research from the University of Virginia School of Medicine suggests.
Much of the world's electronic waste is being shipped to China for recycling and the cottage industry that has sprung up there to recover usable materials from computers, cell phones, televisions and other goods may be creating significant health and environmental hazards.
Israeli researchers conducted an important study to determine if the Pfizer-BioNTech BNT162b2 vaccine had become less effective in preventing infection.
DBV Technologies (DBV), a biotech company specializing in food allergy with innovative products for diagnosis and treatment, announced today the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application. DBV Technologies will begin clinical investigation of its lead food allergy desensitization candidate, VIASKIN® PEANUT, for the desensitization to peanut allergy. The Company expects to commence recruitment of peanut allergy patients at several medical centers in the U.S. this month.
› Verified 7 days ago
Jonathan Ho, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9100 Dr Martin Luther King Jr St N, Apt 1006, St Petersburg, FL 33702 Phone: 859-333-4692 | |
Dr. Ilgar Isskenderov, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2195 66th St N, St Petersburg, FL 33710 Phone: 727-347-2803 | |
Tracy Svane, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8151 Dr Martin Luther King Jr St N, St Petersburg, FL 33702 Phone: 727-576-3826 | |
Ms. Denelle Lynn Hall, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6158 Palma Del Mar Blvd S, 201b, St Petersburg, FL 33715 Phone: 941-721-0649 | |
Dr. Tamara Lynn Steele, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3030 1st Ave N, St Petersburg, FL 33713 Phone: 727-322-5200 | |
Arthur Jackson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1344 22nd St S, St Petersburg, FL 33712 Phone: 727-824-8131 | |
Amanda Memken, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 6th Ave S, Pharmacy Department, St Petersburg, FL 33701 Phone: 727-767-8630 |